Sponsors / TRAW
TRAW

Traws Pharma, Inc.

Company identity checked against sources

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
3Trials in this database
6Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19NCT07157007TRAWPhase 2Recruiting2026-02Estimated
This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaNCT07371650TRAWPhase 2Active not recruiting2026-12Estimated
Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNCT07503405TRAWPhase 2Not yet recruiting2026-11Estimated

Latest recorded trial changes

This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate Influenza

NCT07371650 · Traws Pharma, Inc.

· 4 fields changed

Participant count type changed

− Before

Actual

+ After

Estimated

Enrollment · participant count changed

− Before

0 participants (actual)

+ After

105 participants (planned)

Primary completion date changed

− Before

Jun 2026

+ After

Dec 2026

Recruitment status changed

− Before

Withdrawn

+ After

Active not recruiting

Check registry source